Goldman Sachs’s Corbus Pharmaceuticals CRBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $301K | Sell |
43,674
-14,262
| -25% | -$98.4K | ﹤0.01% | 4524 |
|
|
2025
Q1 | $308K | Buy |
57,936
+762
| +1% | +$4.05K | ﹤0.01% | 4497 |
|
|
2024
Q4 | $675K | Buy |
57,174
+7,754
| +16% | +$91.5K | ﹤0.01% | 4137 |
|
|
2024
Q3 | $1.02M | Sell |
49,420
-11,108
| -18% | -$229K | ﹤0.01% | 3744 |
|
|
2024
Q2 | $2.74M | Sell |
60,528
-45,850
| -43% | -$2.07M | ﹤0.01% | 3010 |
|
|
2024
Q1 | $4.17M | Buy |
+106,378
| New | +$4.17M | ﹤0.01% | 2721 |
|
|
2022
Q4 | – | Sell |
-2,953
| Closed | -$15K | – | 5178 |
|
|
2022
Q3 | $15K | Sell |
2,953
-238
| -7% | -$1.21K | ﹤0.01% | 5213 |
|
|
2022
Q2 | $24K | Buy |
+3,191
| New | +$24K | ﹤0.01% | 5394 |
|
|
2022
Q1 | – | Sell |
-2,850
| Closed | -$53K | – | 5764 |
|
|
2021
Q4 | $53K | Sell |
2,850
-2,374
| -45% | -$44.1K | ﹤0.01% | 5344 |
|
|
2021
Q3 | $160K | Buy |
5,224
+3,174
| +155% | +$97.2K | ﹤0.01% | 4937 |
|
|
2021
Q2 | $113K | Sell |
2,050
-5,116
| -71% | -$282K | ﹤0.01% | 5088 |
|
|
2021
Q1 | $423K | Buy |
7,166
+5,139
| +254% | +$303K | ﹤0.01% | 4466 |
|
|
2020
Q4 | $76K | Sell |
2,027
-1,668
| -45% | -$62.5K | ﹤0.01% | 4508 |
|
|
2020
Q3 | $199K | Buy |
3,695
+1,395
| +61% | +$75.1K | ﹤0.01% | 4060 |
|
|
2020
Q2 | $579K | Sell |
2,300
-106
| -4% | -$26.7K | ﹤0.01% | 3517 |
|
|
2020
Q1 | $378K | Buy |
2,406
+440
| +22% | +$69.1K | ﹤0.01% | 3635 |
|
|
2019
Q4 | $322K | Sell |
1,966
-946
| -32% | -$155K | ﹤0.01% | 3828 |
|
|
2019
Q3 | $425K | Sell |
2,912
-921
| -24% | -$134K | ﹤0.01% | 3654 |
|
|
2019
Q2 | $797K | Sell |
3,833
-2,227
| -37% | -$463K | ﹤0.01% | 3307 |
|
|
2019
Q1 | $1.26M | Buy |
6,060
+560
| +10% | +$117K | ﹤0.01% | 3157 |
|
|
2018
Q4 | $964K | Buy |
5,500
+3,262
| +146% | +$572K | ﹤0.01% | 3145 |
|
|
2018
Q3 | $507K | Buy |
2,238
+322
| +17% | +$72.9K | ﹤0.01% | 3446 |
|
|
2018
Q2 | $290K | Buy |
1,916
+138
| +8% | +$20.9K | ﹤0.01% | 3741 |
|
|
2018
Q1 | $325K | Buy |
1,778
+748
| +73% | +$137K | ﹤0.01% | 3673 |
|
|
2017
Q4 | $219K | Buy |
+1,030
| New | +$219K | ﹤0.01% | 3790 |
|